Structural studies of p53 inactivation by DNA-contact mutations and its rescue by suppressor mutations via alternative protein–DNA interactions
暂无分享,去创建一个
Remo Rohs | R. Rohs | H. Rozenberg | Z. Shakked | Y. Diskin‐Posner | A. Eldar | Zippora Shakked | Yael Diskin-Posner | Amir Eldar | Haim Rozenberg
[1] G. Hong,et al. Nucleic Acids Research , 2015, Nucleic Acids Research.
[2] A. Fersht,et al. Rescuing the function of mutant p53 , 2001, Nature Reviews Cancer.
[3] K. Kinzler,et al. Definition of a consensus binding site for p53 , 1992, Nature Genetics.
[4] Emil Alexov,et al. Rapid grid‐based construction of the molecular surface and the use of induced surface charge to calculate reaction field energies: Applications to the molecular systems and geometric objects , 2002, J. Comput. Chem..
[5] M. J. Adams. Preparation and Analysis of Protein Crystals , 1983 .
[6] V. Rotter,et al. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations. , 2009, Journal of molecular biology.
[7] Ying Wang,et al. Structure of the human p53 core domain in the absence of DNA. , 2007, Acta crystallographica. Section D, Biological crystallography.
[8] Thomas J Petty,et al. An induced fit mechanism regulates p53 DNA binding kinetics to confer sequence specificity , 2011, The EMBO journal.
[9] T. Halazonetis,et al. Structure–based rescue of common tumor–derived p53 mutants , 1996, Nature Medicine.
[10] S. Loh. The missing zinc: p53 misfolding and cancer. , 2010, Metallomics : integrated biometal science.
[11] Randy J. Read,et al. Acta Crystallographica Section D Biological , 2003 .
[12] J. Butler,et al. Zn(2+)-dependent misfolding of the p53 DNA binding domain. , 2007, Biochemistry.
[13] Yongheng Chen,et al. Crystal structure of the p53 core domain bound to a full consensus site as a self-assembled tetramer. , 2010, Structure.
[14] Z. Otwinowski,et al. Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.
[15] M. Olivier,et al. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database , 2007, Human mutation.
[16] K. Malecka,et al. Crystal Structure of a p53 Core Tetramer Bound to DNA , 2008, Oncogene.
[17] J. Levine,et al. Surfing the p53 network , 2000, Nature.
[18] P. Jeffrey,et al. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. , 1994, Science.
[19] Collaborative Computational,et al. The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.
[20] A. Levine,et al. Surfing the p53 network , 2000, Nature.
[21] J. Thornton,et al. PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .
[22] R. Lavery,et al. Defining the structure of irregular nucleic acids: conventions and principles. , 1989, Journal of biomolecular structure & dynamics.
[23] A. Fersht,et al. Structural basis for understanding oncogenic p53 mutations and designing rescue drugs , 2006, Proceedings of the National Academy of Sciences.
[24] Shunsuke Kato,et al. The screening of the second‐site suppressor mutations of the common p53 mutants , 2007, International journal of cancer.
[25] K. Wiman,et al. Pharmacological reactivation of mutant p53: from protein structure to the cancer patient , 2010, Oncogene.
[26] B. Honig,et al. Diversity in DNA recognition by p53 revealed by crystal structures with Hoogsteen base pairs , 2010, Nature Structural &Molecular Biology.
[27] A. Fersht,et al. Structural biology of the tumor suppressor p53 and cancer-associated mutants. , 2007, Advances in cancer research.
[28] R. Mann,et al. The role of DNA shape in protein-DNA recognition , 2009, Nature.
[29] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[30] Ting Wang,et al. A global suppressor motif for p53 cancer mutants. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[31] J. Shay,et al. A transcriptionally active DNA-binding site for human p53 protein complexes , 1992, Molecular and cellular biology.
[32] Magali Olivier,et al. TP53 mutations in human cancers: origins, consequences, and clinical use. , 2010, Cold Spring Harbor perspectives in biology.
[33] A. Fersht,et al. Structures of p53 Cancer Mutants and Mechanism of Rescue by Second-site Suppressor Mutations* , 2005, Journal of Biological Chemistry.
[34] C. Prives,et al. Transcriptional regulation by p53. , 2010, Cold Spring Harbor perspectives in biology.
[35] M. Oren,et al. Decision making by p53: life, death and cancer , 2003, Cell Death and Differentiation.
[36] Randy J. Read,et al. Phaser crystallographic software , 2007, Journal of applied crystallography.
[37] A. Levine,et al. The p53 pathway: positive and negative feedback loops , 2005, Oncogene.
[38] A. N. Popov,et al. A quantitative approach to data-collection strategies. , 2006, Acta crystallographica. Section D, Biological crystallography.
[39] C. Harris,et al. The IARC TP53 database: New online mutation analysis and recommendations to users , 2002, Human mutation.
[40] Z. Weng,et al. A Global Map of p53 Transcription-Factor Binding Sites in the Human Genome , 2006, Cell.
[41] M. Kitayner,et al. Structural basis of DNA recognition by p53 tetramers. , 2006, Molecular cell.
[42] A. Fersht,et al. Structure–function–rescue: the diverse nature of common p53 cancer mutants , 2007, Oncogene.